NCT02386800 2026-03-16CINC424A2X01B Rollover ProtocolNovartisPhase 4 Active not recruiting279 enrolled
NCT04710576 2026-03-16AGAVE-201Syndax PharmaceuticalsPhase 2 Active not recruiting241 enrolled 11 charts 1 FDA
NCT01520623 2026-03-05Complement and Graft-versus-host DiseaseAssistance Publique - Hôpitaux de ParisPhase NA Completed70 enrolled
NCT07006506 2026-03-05A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting46 enrolled
NCT07216443 2026-02-23Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeOrca Biosystems, Inc.Phase 2 Recruiting80 enrolled